Lexicon Pharma (LXRX) Reports Q4 EPS of $0.76
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.18 -9.54%
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.76, versus ($0.03) reported last year. Revenue for the quarter came in at $127.3 million, versus $21.5 million reported last year.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Largo restructures $82.2M in debt, extending maturity to 2030
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
